24-25-dihydroxyvitamin-d-3 and Neoplasms

24-25-dihydroxyvitamin-d-3 has been researched along with Neoplasms* in 2 studies

Reviews

2 review(s) available for 24-25-dihydroxyvitamin-d-3 and Neoplasms

ArticleYear
Role of dihydroxyvitamin D(3) and its nuclear receptor in novel directed therapies for cancer.
    General physiology and biophysics, 2006, Volume: 25, Issue:4

    Dihydroxyvitamin D(3) is known to affect broad spectrum of various biochemical and molecular biological reactions in organisms. Research on the role and function of nuclear vitamin D(3) receptors (VDR) playing a role as dihydroxyvitamin D(3) inducible transcription factor belongs to dynamically developing branches of molecular endocrinology. In higher organisms, full functionality of VDR in the form of heterodimer with nuclear 9-cis retinoic acid receptor is essential for biological effects of dihydroxyvitamin D(3). This article summarizes selected effects of biologically active vitamin D(3) acting through their cognate nuclear receptors, and also its potential use in therapy and prevention of various types of cancer.

    Topics: 24,25-Dihydroxyvitamin D 3; Antineoplastic Agents; Drug Delivery Systems; Humans; Neoplasms; Receptors, Calcitriol; Receptors, Cytoplasmic and Nuclear

2006
[Vitamin D and its therapeutic use].
    Annales de medecine interne, 1985, Volume: 136, Issue:2

    Topics: 24,25-Dihydroxyvitamin D 3; Absorption; Adrenal Cortex Hormones; Anticonvulsants; Calcifediol; Calcitriol; Calcium; Chemical Phenomena; Chemistry; Chronic Kidney Disease-Mineral and Bone Disorder; Digestive System Diseases; Dihydroxycholecalciferols; Fanconi Syndrome; Female; Humans; Hydroxycholecalciferols; Hypocalcemia; Hypoparathyroidism; Hypophosphatemia, Familial; Infant, Newborn; Kidney Diseases; Kinetics; Liver Diseases; Menopause; Neoplasms; Osteomalacia; Osteoporosis; Rickets; Vitamin D

1985